Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same
US11820769B2 · kind B2 · utility
0Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2021 |
| Grant date | Nov 21, 2023 |
| Priority date | — |
| Expiry date | Dec 31, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present technology provides triazolopyridin-3-ones or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The triazolopyridin-3-ones or their pharmaceutically acceptable salts exhibit inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.